Sunnyvale, Calif., February
29, 2008
Two of IMPAC’s oncology-specific Electronic Medical Record (EMR)
customers, The West Clinic and Palmetto Hematology Oncology,
have received Hematology & Oncology News & Issues (HONI)
magazine's HOPE (Hematology & Oncology Practice Excellence)
recognition award for "Clinical Best Practices."
Committed to using technology to the advantage of patient care,
The West Clinic was recognized for its "full usage of EMR;
robust clinical trials research program; use of extensive
clinical guidelines; and extensive use of technology." Priding
themselves in providing compassionate care to each of their
patients, Palmetto Hematology Oncology was described as a
“leader within their state and nation in embracing electronic
medical record technology.”
“We believe the use of an oncology-specific EMR can improve the
quality of patient care,” says Jay Hoey, Executive Vice
President Product Creation at Elekta and CEO of IMPAC Medical
Systems, “and are pleased that The West Clinic and Palmetto
Hematology Oncology were recognized as national leaders in their
field.”
Hematology & Oncology News & Issues’ HOPE initiative was created
to encourage the development of practice standard excellence
within community-based cancer centers. By providing examples of
the best models available, it is anticipated that the three-year
initiative will help reshape oncology practices.
The analysis of metrics-based information provided by each
center’s submission, as well as a blind balloting process
conducted by a HONI panel of experts, resulted in the final
selection of each center. To view the February issue featuring
The West Clinic and Palmetto Hematology Oncology, visit
www.honionline.com.
About IMPAC Medical Systems, Inc.
IMPAC Medical
Systems provides healthcare IT solutions that streamline
clinical and business operations across the spectrum of cancer
care. IMPAC’s open integration to multiple healthcare data and
imaging systems offers oncology-specific patient charting and
practice management, as well as best-of-breed systems for
anatomic pathology, clinical laboratory and cancer registry.
With products that range from diagnosis and treatment through
long-term follow-up, IMPAC provides a comprehensive oncology
management solution that helps improve overall communication,
process efficiency, and quality patient care.
IMPAC is part of the Elekta Group, providing oncologists,
radiation therapists, neurosurgeons and many other medical
specialists with state of the art tools to fight cancer and
brain disorders.
With more than 2,000 employees globally, Elekta’s corporate
headquarter is located in Stockholm, Sweden and the company is
listed on the Nordic Exchange under the ticker EKTAb. More
information can be found at
www.impac.com and
www.elekta.com. |
|
Media Inquiries:
Michelle Lee
PR and Advertising Manager
Tel: +1 770-670-2447
michelle.lee@elekta.com
Global Marketing inquiries: Peter Gaccione
Vice President,
Global Marketing
Tel: +1 770-670-2380
peter.gaccione@elekta.com
Investor inquiries:
Peter Ejemyr
Group VP,
Corporate Communications, Tel: +46 733 611 000
peter.ejemyr@elekta.com
Link Disclaimer
|
